Drugs / C1-R212
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02955368 Comparator | Feb → Jul 2017 | hyperlipoproteinemia, hypertensive disorder | Alvogen Korea | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | C1-R212 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02955368 ↗ |